Skip to content

Post-Market Surveillance With a Novel mHealth Platform

Post-Market Surveillance With a Novel mHealth Platform

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03436082
Enrollment
60
Registered
2018-02-19
Start date
2018-01-26
Completion date
2018-12-25
Last updated
2021-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation, Gastrectomy

Brief summary

This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation

Detailed description

The plan is to pilot test a novel patient-led, smartphone-based mobile health platform (called Hugo) for real-world surveillance of outcomes in 60 total patients after medical device use. Research associates will be recruiting patients before they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation. Patients will then be queried about specific symptoms related to their procedure. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes. This pilot project will engage patients to report outcomes while also synchronizing data from their electronic health records and pharmacy accounts to ascertain the ability of emerging mobile health technologies to aid in post-marketing surveillance.

Interventions

DEVICEA mobile health platform

Patients pilot testing the smartphone based, mobile health platform called HUGO. Patients will also be given syncable devices to use that will provide additional insights into their health and health outcomes.Patients will be queried about specific symptoms related to their procedure at enrollment, one week post-procedure, at 4 weeks and again at 8 weeks.

Sponsors

Johnson & Johnson
CollaboratorINDUSTRY
Food and Drug Administration (FDA)
CollaboratorFED
Mayo Clinic
CollaboratorOTHER
Yale University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \>18 * English-speaking * Planned for either a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) or catheter-based atrial fibrillation ablation * Participant is willing and able to read and sign consent and participate in study * Participant has an email account and a mobile device (smartphone or tablet) able to download the necessary applications * Participant is willing to use the mobile health platform and syncable devices (e.g. Fitbit Charge 2) * Attending bariatric surgeon or electrophysiologist (as appropriate) concurs that patient is a candidate for enrollment

Exclusion criteria

Healthy patients Patients who refuse participation

Design outcomes

Primary

MeasureTime frameDescription
Number of Disease-Specific PROMs Completed8 weeksDisease-specific PROMs were collected using email notification to all patients over the course of the study. Disease-specific PROMs were emailed to patients at enrollment (preprocedure) and 1, 4, and 8 weeks post-procedure and were tailored to patients depending on the procedure they received. For each PROM, the date and time that it was emailed to patients, the time it was initiated, and the time at which the final response was received were all available.
Number of Post-Procedure PROMs Completed5 weeksPost-procedure PROMs were collected using email notification to all patients over the course of the study. Post-procedure PROMs were emailed to patients twice weekly for a total of 5 weeks post-procedure. Bariatric surgery patients were asked two questions: (1) if they had pain (yes/no) and, if yes, to rate their pain on a scale of 1-10 and (2) if they had an appetite (yes/no) and, if yes, to rate their appetite on a scale of 1-10. Atrial fibrillation ablation patients were asked about pain, as well as whether they had palpitations and, if yes, to rate both symptoms on a scale of 1-10. For each PROM, the date and time that it was emailed to patients, the time it was initiated, and the time at which the final response was received were all available.
Device Syncs8 weeksDevice syncs are operationally defined as the # of patients who synced their device at all required time points over the 8-week post-procedure period.
Electronic Health Record Data Validation8 weeksFor EHR data, we validated the following components over 8 weeks follow-up: encounter date, encounter type, and encounter primary diagnosis. Specifically, we determined if encounters aggregated by the patient-centered health data sharing platform, Hugo, matched encounters listed in each patient's EHR.

Countries

United States

Participant flow

Participants by arm

ArmCount
Bariatric
(Sleeve Gastrectomy/Roux-en-Y)
30
AF Ablation
Atrial Fibrillation Ablation
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDid not undergo procedure10

Baseline characteristics

CharacteristicAF AblationTotalBariatric
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
14 Participants17 Participants3 Participants
Age, Categorical
Between 18 and 65 years
16 Participants43 Participants27 Participants
Age, Continuous62.4 Years
STANDARD_DEVIATION 10
55.2 Years
STANDARD_DEVIATION 13.5
46.4 Years
STANDARD_DEVIATION 12.5
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United States
30 Participants60 Participants30 Participants
Sex: Female, Male
Female
12 Participants35 Participants23 Participants
Sex: Female, Male
Male
18 Participants25 Participants7 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 290 / 30
other
Total, other adverse events
0 / 290 / 30
serious
Total, serious adverse events
0 / 290 / 30

Outcome results

Primary

Device Syncs

Device syncs are operationally defined as the # of patients who synced their device at all required time points over the 8-week post-procedure period.

Time frame: 8 weeks

Population: Assessed for # of device syncs

ArmMeasureGroupValue (NUMBER)
BariatricDevice SyncsFitbit17 # patients who synced at all time points
BariatricDevice SyncsDisease-Specific (Withings Body Scale/Kardia Mobile)11 # patients who synced at all time points
AF AblationDevice SyncsFitbit14 # patients who synced at all time points
AF AblationDevice SyncsDisease-Specific (Withings Body Scale/Kardia Mobile)15 # patients who synced at all time points
p-value: 0.85Chi-squared
Primary

Electronic Health Record Data Validation

For EHR data, we validated the following components over 8 weeks follow-up: encounter date, encounter type, and encounter primary diagnosis. Specifically, we determined if encounters aggregated by the patient-centered health data sharing platform, Hugo, matched encounters listed in each patient's EHR.

Time frame: 8 weeks

Population: Assessed for # times encounter date, encounter type, and encounter primary diagnosis matched between the data sharing platform, Hugo, and the patient's EHR

ArmMeasureGroupValue (NUMBER)
BariatricElectronic Health Record Data ValidationEncounter Type103 Number of matched records
BariatricElectronic Health Record Data ValidationEncounter Date105 Number of matched records
BariatricElectronic Health Record Data ValidationPrimary Diagnosis103 Number of matched records
AF AblationElectronic Health Record Data ValidationEncounter Date110 Number of matched records
AF AblationElectronic Health Record Data ValidationEncounter Type100 Number of matched records
AF AblationElectronic Health Record Data ValidationPrimary Diagnosis101 Number of matched records
Primary

Number of Disease-Specific PROMs Completed

Disease-specific PROMs were collected using email notification to all patients over the course of the study. Disease-specific PROMs were emailed to patients at enrollment (preprocedure) and 1, 4, and 8 weeks post-procedure and were tailored to patients depending on the procedure they received. For each PROM, the date and time that it was emailed to patients, the time it was initiated, and the time at which the final response was received were all available.

Time frame: 8 weeks

Population: Assessed for # disease-specific PROMs completed

ArmMeasureValue (NUMBER)
BariatricNumber of Disease-Specific PROMs Completed64 # PROMs completed
AF AblationNumber of Disease-Specific PROMs Completed59 # PROMs completed
p-value: 0.04Chi-squared
Primary

Number of Post-Procedure PROMs Completed

Post-procedure PROMs were collected using email notification to all patients over the course of the study. Post-procedure PROMs were emailed to patients twice weekly for a total of 5 weeks post-procedure. Bariatric surgery patients were asked two questions: (1) if they had pain (yes/no) and, if yes, to rate their pain on a scale of 1-10 and (2) if they had an appetite (yes/no) and, if yes, to rate their appetite on a scale of 1-10. Atrial fibrillation ablation patients were asked about pain, as well as whether they had palpitations and, if yes, to rate both symptoms on a scale of 1-10. For each PROM, the date and time that it was emailed to patients, the time it was initiated, and the time at which the final response was received were all available.

Time frame: 5 weeks

Population: Assessed for # PROMs completed

ArmMeasureValue (NUMBER)
BariatricNumber of Post-Procedure PROMs Completed203 # PROMs completed
AF AblationNumber of Post-Procedure PROMs Completed237 # PROMs completed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026